Small molecules are leading to big discoveries in human health. Using metabolomics, proteomics, and biophysical techniques, researchers screen for small molecules, metabolites, or proteins that target disease mechanisms. In this webinar, experts will discuss new approaches to identify small therapeutic candidates targeting diabetes and Alzheimer’s disease.
Topics to be covered
Bridget Wagner, PhD
Director, Pancreatic Cell Biology and Metabolic Disease
Broad Institute, MIT and Harvard
Gabriella Heller, PhD
University College London